CEPT - 医索

找到约 48 条结果

“别吃我靶点”CD47：肿瘤免疫疗法的新星靶点

7月31日，ALX Oncology宣布，其在研CD47抑制剂evorpacept用于既往接受过抗HER2药物治疗的HER2阳性晚期胃癌(GC)或胃食管交界处癌(GEJ)患者的II期ASPEN-06研究取得积极结果。evorpacept在实体瘤研究中取得的积极信号为CD47靶点研发领域燃起.....

学术资讯 - 临床医学

Safety, tolerability and efficacy of 21Pb-DOTAMTATE asa targeted alpha therapy for subjects with unresectableor metastatic somatostatin receptor-expressinggastroenteropancreatic neuroendocrine

医客学院 - 会议报告集

SACI-0 HR A randomized phase ll trial ofsacituzumab govitecan with or without pembrolizumabin patients with metastatic hormone receptor-positive!HER2-negative breast cancer

医客学院 - 会议报告集

H3B-6545 in women with locally advancedmetastaticestrogen receptor-positive,HER2-negative breast cancer

医客学院 - 会议报告集

First-line inavolisibplacebo palbociclib fulvestrant(InavoPbo Palbo Fulv) in patients (pts) with PiK3cA-mutated.hormone receptor-positive, HER2-negative locally advancedmetastaticbreast cancer

医客学院 - 会议报告集

Development and validation of RsclinN toolfor hormone receptor-positive(HR ),HER2-negative(HER2-)node-positive breast cancer

医客学院 - 会议报告集

Datopotamab deruxtecan (Dato-DXd)vs chemotherapy inpreviously-treated inoperable or metastatic hormonereceptor-positive, HER2-negative (HR HER2-) breast cancerPatient-reported outcomes(PROs) from

医客学院 - 会议报告集

Balancing efficacy and quality of lifein hormone receptor-positivemetastatic breast cancer

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

Science子刊：睡眠不足如何让人变傻：明星分子TREM2让小胶质细胞对Aβ“贪多嚼不烂”，降低Aβ清除能力

关键词：阿尔茨海默病；蛋白质组学引言：表达在小胶质细胞的触发受体2（triggering receptor expressed on myeloid cells 2, TREM2）是一种主要在小胶质细胞上表达的免疫调节受体。小胶质细胞是中枢神经系统（CN.......

学术资讯 - 临床研究

首页
上一页
1
2
3
4
5
下一页
尾页

今日实时热搜